Infinity Pharmaceuticals, Inc. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 47 rows in 2012. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2012-12-14: Reporting owner SELBY NORMAN C; Form 4; Security Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2012-12-07: Reporting owner Perkins Adelene Q; Form 4; Security Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2012-12-07: Reporting owner Perkins Adelene Q; Form 4; Security Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2012-12-07: Reporting owner Perkins Adelene Q; Form 4; Security Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2012-12-14 | SELBY NORMAN C Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,500 2,500 owned after | $8.87 exercise price | 2012-12-18 | |
| 2012-12-07 | Perkins Adelene Q Director, Officer (Pres & Chief Executive Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −22,103 0 owned after | $3.48 exercise price | 2012-12-10 | |
| 2012-12-07 | Perkins Adelene Q Director, Officer (Pres & Chief Executive Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −331 0 owned after | $3.48 exercise price | 2012-12-10 | |
| 2012-12-07 | Perkins Adelene Q Director, Officer (Pres & Chief Executive Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −29,432 0 owned after | $13.59 exercise price | 2012-12-10 | |
| 2012-12-07 | Perkins Adelene Q Director, Officer (Pres & Chief Executive Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,204 0 owned after | $9.80 exercise price | 2012-12-10 | |
| 2012-12-07 | Perkins Adelene Q Director, Officer (Pres & Chief Executive Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −13,927 0 owned after | $7.18 exercise price | 2012-12-10 | |
| 2012-12-07 | Perkins Adelene Q Director, Officer (Pres & Chief Executive Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −23,070 340,930 owned after | $6.25 exercise price | 2012-12-10 | |
| 2012-12-07 | Perkins Adelene Q Director, Officer (Pres & Chief Executive Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −76,930 83,620 owned after | $5.94 exercise price | 2012-12-10 | |
| 2012-11-27 | EVNIN ANTHONY B Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,875 0 owned after | $15.04 exercise price | 2012-11-28 | |
| 2012-11-27 | EVNIN ANTHONY B Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,407 0 owned after | $9.23 exercise price | 2012-11-28 | |
| 2012-11-27 | EVNIN ANTHONY B Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −9,375 0 owned after | $7.70 exercise price | 2012-11-28 | |
| 2012-11-27 | EVNIN ANTHONY B Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −9,375 0 owned after | $5.63 exercise price | 2012-11-28 | |
| 2012-11-27 | EVNIN ANTHONY B Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,625 0 owned after | $5.63 exercise price | 2012-11-28 | |
| 2012-11-27 | EVNIN ANTHONY B Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −9,375 0 owned after | $6.74 exercise price | 2012-11-28 | |
| 2012-11-27 | EVNIN ANTHONY B Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,625 0 owned after | $6.74 exercise price | 2012-11-28 | |
| 2012-11-27 | EVNIN ANTHONY B Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 0 owned after | $6.80 exercise price | 2012-11-28 | |
| 2012-11-27 | EVNIN ANTHONY B Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,000 0 owned after | $6.80 exercise price | 2012-11-28 | |
| 2012-11-26 | Lindblom Christopher M Officer (See Remarks) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 10,000 owned after | $14.33 exercise price | 2012-11-27 | |
| 2012-11-26 | Lindblom Christopher M Officer (See Remarks) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,885 0 owned after | $9.80 exercise price | 2012-11-27 | |
| 2012-10-15 | SELBY NORMAN C Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,000 5,000 owned after | $8.87 exercise price | 2012-10-16 | |
| 2012-09-04 | Santabarbara Pedro Officer (Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −9,200 150,800 owned after | $6.50 exercise price | 2012-09-06 | |
| 2012-07-23 | BLOCH LAWRENCE E Officer (EVP, CFO & CBO) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +200,000 200,000 owned after | $15.85 exercise price | 2012-07-25 | |
| 2012-05-16 | LANDER ERIC S Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,000 6,000 owned after | $12.94 exercise price | 2012-05-18 | |
| 2012-05-16 | Holtzman Steven H Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,000 6,000 owned after | $12.94 exercise price | 2012-05-18 | |
| 2012-05-16 | Holtzman Steven H Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,000 12,000 owned after | $12.94 exercise price | 2012-05-18 | |
| 2012-05-16 | Lee Patrick Pak-Tin Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,000 6,000 owned after | $12.94 exercise price | 2012-05-18 | |
| 2012-05-16 | VENUTI MICHAEL C Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,000 6,000 owned after | $12.94 exercise price | 2012-05-18 | |
| 2012-05-16 | VENUTI MICHAEL C Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,000 4,000 owned after | $12.94 exercise price | 2012-05-18 | |
| 2012-05-16 | Lynch Thomas J. Jr. Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,000 6,000 owned after | $12.94 exercise price | 2012-05-18 | |
| 2012-05-16 | Babler Martin Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,000 6,000 owned after | $12.94 exercise price | 2012-05-18 | |
| 2012-05-16 | Babler Martin Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +2,000 2,000 owned after | $12.94 exercise price | 2012-05-18 | |
| 2012-05-16 | SELBY NORMAN C Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,000 6,000 owned after | $12.94 exercise price | 2012-05-18 | |
| 2012-05-16 | Fyfe Gwen A. Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,000 6,000 owned after | $12.94 exercise price | 2012-05-18 | |
| 2012-05-16 | SMITH IAN F Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,000 6,000 owned after | $12.94 exercise price | 2012-05-18 | |
| 2012-05-16 | SMITH IAN F Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,000 4,000 owned after | $12.94 exercise price | 2012-05-18 | |
| 2012-05-16 | EVNIN ANTHONY B Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,000 6,000 owned after | $12.94 exercise price | 2012-05-17 | |
| 2012-05-16 | EVNIN ANTHONY B Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $12.94 exercise price | 2012-05-17 | |
| 2012-03-08 | SELBY NORMAN C Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $8.87 exercise price | 2012-03-12 | |
| 2012-03-08 | Fyfe Gwen A. Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $8.87 exercise price | 2012-03-12 | |
| 2012-01-06 | Tucker Winselow S. Jr. Officer (VP, Marketing) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,104 30,104 owned after | $7.93 exercise price | 2012-01-09 | |
| 2012-01-06 | Quirk Gerald E Officer (See Remarks) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +40,000 40,000 owned after | $7.93 exercise price | 2012-01-09 | |
| 2012-01-06 | Palombella Vito J. Officer (Chief Scientific Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +47,136 47,136 owned after | $7.93 exercise price | 2012-01-09 | |
| 2012-01-06 | Hamermesh Joshua Officer (See Remarks) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +11,844 11,844 owned after | $7.93 exercise price | 2012-01-09 | |
| 2012-01-06 | Santabarbara Pedro Officer (Chief Medical Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +47,136 47,136 owned after | $7.93 exercise price | 2012-01-09 | |
| 2012-01-06 | Perkins Adelene Q Director, Officer (See Remarks) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +191,750 191,750 owned after | $7.93 exercise price | 2012-01-09 | |
| 2012-01-06 | Lindblom Christopher M Officer (See Remarks) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,104 30,104 owned after | $7.93 exercise price | 2012-01-09 | |
| 2012-01-06 | ADAMS JULIAN Officer (President of R&D) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +126,850 126,850 owned after | $7.93 exercise price | 2012-01-09 |